Losartan Potassium
Product Images NDC 71335-1439

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 71335-1439). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1.jpg (Fig1)

A line graph comparing the percentage of patients with a primary endpoint over a study duration of 66 months for Atenolol and Losartan. The graph shows Atenolol with a dashed line and Losartan with a solid line, including a note of adjusted risk reduction of 13% with a p-value of 0.021.*

FDA Label Image

Fig2.jpg (Fig2)

A line graph comparing the percentage of patients with fatal or non-fatal stroke over 66 study months between Atenolol (dashed line) and Losartan (solid line). The graph shows lower stroke incidence in the Losartan group, with an adjusted risk reduction of 25% (p=0.001). The x-axis represents study duration in months, and the y-axis shows the percentage of affected patients.*

FDA Label Image

Fig3.jpg (Fig3)

A forest plot chart comparing event rates and hazard ratios for Losartan and Atenolol across different patient subgroups. The chart includes primary composite events and stroke (fatal/non-fatal) events, with hazard ratios illustrated on a logarithmic scale favoring either Losartan or Atenolol. Subgroups are divided by age, gender, race, ISH status, diabetes status, and history of cardiovascular disease (CVD), with corresponding event rates and number of patients listed.*

FDA Label Image

Fig4.jpg (Fig4)

A line graph comparing the percentage of patients with an event over 48 months between Losartan and placebo groups. The solid line represents Losartan, and the dashed line represents placebo, showing a 16.1% risk reduction with Losartan (p=0.022). The x-axis is labeled 'Months' and the y-axis '% patients with event.'*

FDA Label Image

Losartan-chem-structure-11-04-2021 (Image 01)

Chemical structure of Losartan Potassium, showing its molecular arrangement with chlorine, nitrogen, potassium, and other atoms forming the active ingredient molecule.*

FDA Label Image

Label (Lbl713351439)

Losartan Potassium 25mg tablet label packaged by Bryant Ranch Prepack. The label includes the comparison to Cozaar 25mg tablet by West-Ward Pharmaceuticals Corp., dosage form as tablet, package size of 90, and storage conditions at 20°-25°C (68°-77°F). The label also displays the NDC number 71335-1439-1 and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.